|
Market Cap (13-Jul) $6,957,488 (1,468th) |
Close (30-Jun) $0.042 |
Volume (30-Jun) 582,113 |
Shortsold (6-Dec) 611,822 (0.21%) (374th) |
|
52w High $0.079 |
52w Low $0.015 |
P/E - |
EPS -0.02 |
ACR released this announcement to the ASX on 8 August 2022, 9:33. The announcement is marked as price sensitive, and is 2 page(s) in length and 153.25kb in size.
You can view all announcements from ACR and see how they appear on a price chart on the announcements page.
At the date of this announcement, ACR was 0.004% short sold according to ASIC data. It was ranked the 605th most shorted stock on the ASX. It is now ranked as the 374th most shorted stock on the ASX with 0.210% of total shares short sold as of the latest reported data (06 December 2024).
| Other Recent Announcements from ACR | |
|---|---|
| Appendix 3Y Brooke | 16 June 2023, 9:27 |
| Application for quotation of securities - ACR | 16 June 2023, 9:25 |
| 4th FDA ANDA approval received - Dapsone Gel, 5% | 7 June 2023, 10:35 |
| Acrux's sixth generic dossier accepted by FDA for review | 8 August 2022, 9:33 |
| Updated Corporate Policy - Code of Conduct | 28 June 2022, 12:14 |
| Appendix 3Y - Oldham | 22 June 2022, 13:43 |
| Application for quotation of securities - ACR | 22 June 2022, 13:36 |
You must be logged in to post a reply.
